Comments for: FDA probing suicide, drug link

WASHINGTON – The Food and Drug Administration said Thursday it is investigating a possible link between Merck’s best-selling Singulair and suicide. FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy… Read More
Read more
By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.